Cargando…
Clinical Improvement With Pyridostigmine in a Patient With Acetylcholine Receptor Antibody-Associated Autoimmune Gastrointestinal Dysmotility
Autoimmune gastrointestinal dysmotility (AGID) is a rare form of limited autoimmune dysautonomia caused by autoantibodies against the enteric nervous system. Our patient was a 53-year-old man with 1 year of bloating, intolerance of oral intake, and recurrent ileus. Esophageal manometry showed aperis...
Autores principales: | Sekhri, Shaina, Massey, Benson, Beniwal-Patel, Poonam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239654/ https://www.ncbi.nlm.nih.gov/pubmed/35774847 http://dx.doi.org/10.14309/crj.0000000000000796 |
Ejemplares similares
-
Autoimmune Gastrointestinal Dysmotility in a Patient With HIV Treated With Methylprednisolone and Pyridostigmine
por: Gromisch, Christopher M., et al.
Publicado: (2021) -
New Insights into the Understanding of Gastrointestinal Dysmotility
por: Ohlsson, Bodil, et al.
Publicado: (2007) -
Gastrointestinal dysmotility in critically ill patients
por: Ladopoulos, Theodoros, et al.
Publicado: (2018) -
Expression of Luteinizing Hormone Receptor in the Gastrointestinal Tract in Patients with and without Dysmotility
por: Hammar, Oskar, et al.
Publicado: (2012) -
Recent Advances in the Management of Severe Gastrointestinal Dysmotility
por: Vasant, Dipesh H, et al.
Publicado: (2021)